SCHEMBL6325323

SCHEMBL6325323

CCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.67
▸ ALDH1A1 P00352 3/20 0.62
▸ LMNA P02545 2/20 0.61
▸ PAM P19021 2/20 0.59
▸ CES2 O00748 3/20 0.59
▸ CES1 P23141 3/20 0.59
▸ MAPT P10636 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ PPARG P37231 6/20 0.56
▸ PPARD Q03181 6/20 0.56
▸ PPARA Q07869 6/20 0.56
▸ HDAC11 Q96DB2 5/20 0.56
▸ TSHR P16473 4/20 0.56
▸ GPR84 Q9NQS5 4/20 0.56
▸ TLR2 O60603 2/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ FABP4 P15090 2/20 0.56
▸ PTPN1 P18031 2/20 0.56
▸ SLC22A6 Q4U2R8 1/20 0.56
▸ SLC22A8 Q8TCC7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1627038 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL2166981 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL8843651 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL20529845 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL21647233 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL291030 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL2762456 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL15527889 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL6884987 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2
SCHEMBL20448528 1.00 DGKA (0.67) DGKAALDH1A1LMNAPAMCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118267317-A Soothing preparation capable of remarkably reducing skin surface temperature and preparation method thereof 博汇美萃生物工程技术(广东)有限公司 2024-07-02 — — CN claimed
CN-108158858-A A kind of water outlet muffin and preparation method thereof 广州雅纯化妆品制造有限公司 2018-06-15 — — CN claimed
CN-118267317-A Soothing preparation capable of remarkably reducing skin surface temperature and preparation method thereof 博汇美萃生物工程技术(广东)有限公司 2024-07-02 — — CN disclosed
CN-118267317-A Soothing preparation capable of remarkably reducing skin surface temperature and preparation method thereof 博汇美萃生物工程技术(广东)有限公司 2024-07-02 — — CN disclosed
CN-115397431-A ECLITASERTIB for the treatment of disorders involving systemic excessive inflammatory response 建新公司 2022-11-25 — — CN disclosed
CN-115348862-A Therapeutic tyrosine kinase inhibitors for Relapsing Multiple Sclerosis (RMS) 建新公司 2022-11-15 — — CN disclosed
CN-107920972-B Emulsion composition with high oil content 罗地亚经营管理公司 2021-11-09 — — CN disclosed
CN-107531685-B Compounds with antitumor activity AB科学有限公司 2021-04-23 — — CN disclosed
CN-107383167-B Antioxidant active peptide and application thereof 温州千瑞生物科技有限公司 2021-02-09 — — CN disclosed
CN-107337714-B Antihistaminic, antiallergic peptides and uses thereof 温州千瑞生物科技有限公司 2020-09-22 — — CN disclosed
CN-107118259-B Active peptide and whitening cream containing same 温州千瑞生物科技有限公司 2020-08-18 — — CN disclosed
CN-103458880-A Unit dose form for oral administration THRESHOLD PHARMACEUTICALS INC 2013-12-18 — — CN disclosed
CN-101309587-B Oil-in-water formulations of avermectins CHEMINOVA AS 2013-08-28 — — CN disclosed
CN-103096720-A Bismuth-thiols as preservatives for agricultural, industrial and other uses MICROBION CORP 2013-05-08 — — CN disclosed
CN-103079557-A Bismuth-thiols as antibacterial agents for biomedical and other uses including treatment of bacterial biofilms MICROBION CORP 2013-05-01 — — CN disclosed
CN-101309587-A Oil-in-water formulations of avermectins CHEMINOVA AS (DK) 2008-11-19 — — CN disclosed
CN-1937998-A O/W gel compositions comprising wax COGNIS IP MAN GMBH (DE) 2007-03-28 — — CN disclosed
CN-1720895-A Cosmetic composition comprising a defined silicone polymer and a film former OREAL (FR) 2006-01-18 — — CN disclosed
US-20050002994-A1 Cosmetic or dermatological impregnated tissues BEIERSDORF AG (DE) 2005-01-06 — — US disclosed
CN-1455661-A Novel cosmetic, personal care, detergent and nutritional supplement compositions containing bioactive glass and methods of making and using the same SCHOTT GLAS (DE) 2003-11-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050002994-A1 Cosmetic or dermatological impregnated tissues CUTA, KAT8, PWWP2B DGKA 274/4885ALDH1A1 4456/4885LMNA 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback